跳至主要内容
临床试验/NCT06064305
NCT06064305尚未招募不适用

Transcriptional and Proteomic Analysis of Acute Kidney Injury

University Hospital Muenster0 个研究点目标入组 60 人开始时间: 2023年9月29日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
60
主要终点
Correlation of transcriptional and proteomic gene regulation in tissue with clinical molecular Imaging and AKI biomarkers.

研究概览

简要总结

Acute kidney injury is associated with worsened outcome for critically ill patients. Sepsis-associated and non-septic cardiothoracic surgery associated AKI have been reported, nonetheless, precise pathomechanistic differences as well as detectability of transcriptional and proteomic changes in correlation with imaging and plasma markers are unclear.

详细描述

Acute kidney injury is a common and detrimental finding in critically ill/sepsis patients as well as non-septic patients post cardiothoracic surgery. In many cases renal replacement therapy is required and an acute kidney injury is linked to increased morbidity and mortality in intensive care patients. Using routinely obtained clinical samples as well as imaging data, this observational trial investigates the transcriptomic and proteomic determinants detectable in septic and non-septic AKI patient subsets and their correlation with outcome and AKI diagnostic parameters.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 150 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Correlation of transcriptional and proteomic gene regulation in tissue with clinical molecular Imaging and AKI biomarkers.

时间窗: Through study completion, an average of 1 year.

Proteomic and RNAseq-based multi-omics pattern recognition.

次要结局

  • RRT incidence(28 days)
  • Further organ failure based on systemic assessment(Through study completion, an average of 1 year.)
  • Hospital length of stay(Through study completion, an average of 1 year.)
  • Mortality(28 day)
  • ICU length of stay(Through study completion, an average of 1 year.)

研究者

发起方
University Hospital Muenster
申办方类型
Other
责任方
Sponsor

相似试验